PCSK9-IN-11 (compound 5r) is a potent PCSK9 inhibitor with oral activity, exhibiting inhibitory activity on PCSK9 transcription in HepG2 cells (IC50 = 5.7 µM) and capable of increasing LDL receptor (LDLR) protein levels. PCSK9-IN-11 is applicable for atherosclerosis research.
Molecular Weight:
381.789
Purity:
99.10%
CAS Number:
[2882035-56-3]
Formula:
C16H17ClFN5O3
Target:
Others|||LDLR
T67776
T67776
* VAT and and shipping costs not included. Errors and price changes excepted
